The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
- PMID: 8664130
- PMCID: PMC2074552
- DOI: 10.1038/bjc.1996.294
The relationship between weight loss and interleukin 6 in non-small-cell lung cancer
Abstract
Markers of the inflammatory response, interleukin 6, C-reactive protein, albumin and full blood count, were measured in non-small-cell lung cancer (NSCLC) patients (n = 21) with and without weight loss ( > 5%). There were significant increases in circulating C-reactive protein (P < 0.001), interleukin 6 (P < 0.01) and platelets (P < 0.01) in the weight-losing group. Moreover, there was a statistically significant correlation (r = 0.785, P < 0.001) between interleukin 6 and C-reactive protein concentrations. These results are consistent with interleukin 6 and the acute phase response promoting weight loss in NSCLC.
Similar articles
-
Adiponectin and the systemic inflammatory response in weight-losing patients with non-small cell lung cancer.Cytokine. 2004 Jul 21-Aug 7;27(2-3):90-2. doi: 10.1016/j.cyto.2004.03.017. Cytokine. 2004. PMID: 15242698
-
[Evaluation of IL-6 level in serum and bronchoalveolar lavage fluid of patients with non-small cell lung cancer (NSCLC)].Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005 Jul;21(4):507-9. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 2005. PMID: 15989803 Chinese.
-
Osteopontin as a marker of weight loss in lung cancer.Scand J Clin Lab Invest. 2011 Dec;71(8):690-4. doi: 10.3109/00365513.2011.621549. Epub 2011 Oct 21. Scand J Clin Lab Invest. 2011. PMID: 22017168
-
The relationship between circulating concentrations of C-reactive protein, inflammatory cytokines and cytokine receptors in patients with non-small-cell lung cancer.Br J Cancer. 2004 Dec 13;91(12):1993-5. doi: 10.1038/sj.bjc.6602248. Br J Cancer. 2004. PMID: 15570310 Free PMC article.
-
Acute-phase reactants and plasma trace element concentrations in non-small cell lung cancer patients and controls.Nutr Cancer. 1997;28(3):308-12. doi: 10.1080/01635589709514592. Nutr Cancer. 1997. PMID: 9343841
Cited by
-
The Clinical Relevance of Selected Cytokines in Newly Diagnosed Multiple Myeloma Patients.Biomedicines. 2023 Nov 9;11(11):3012. doi: 10.3390/biomedicines11113012. Biomedicines. 2023. PMID: 38002012 Free PMC article.
-
Tumor Cytokine-Induced Hepatic Gluconeogenesis Contributes to Cancer Cachexia: Insights from Full Body Single Nuclei Sequencing.bioRxiv [Preprint]. 2023 May 18:2023.05.15.540823. doi: 10.1101/2023.05.15.540823. bioRxiv. 2023. PMID: 37292804 Free PMC article. Preprint.
-
Orchestration of mesenchymal plasticity and immune evasiveness via rewiring of the metabolic program in pancreatic ductal adenocarcinoma.Front Oncol. 2022 Nov 3;12:1005566. doi: 10.3389/fonc.2022.1005566. eCollection 2022. Front Oncol. 2022. PMID: 36408139 Free PMC article. Review.
-
Transforming Growth Factor-Beta Signaling in Cancer-Induced Cachexia: From Molecular Pathways to the Clinics.Cells. 2022 Aug 28;11(17):2671. doi: 10.3390/cells11172671. Cells. 2022. PMID: 36078078 Free PMC article. Review.
-
Decreased miR-497-5p Suppresses IL-6 Induced Atrophy in Muscle Cells.Cells. 2021 Dec 14;10(12):3527. doi: 10.3390/cells10123527. Cells. 2021. PMID: 34944037 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
